For companies involved in the commercialisation of enantiomerically-pure drugs, CHIRAL TECHNOLOGIES EUROPE and DAICEL can assist in complete outsourcing of drug manufacturing needs. Our facility at Arai (Japan) is equipped to perform upstream or downstream chemical synthesis in addition to conducting multi-ton scale separations. All our separation processes follow good laboratory practises (GLP) and can be undertaken under current Good Manufacturing Practice (cGMP) if required.
We at CHIRAL TECHNOLOGIES EUROPE and DAICEL can assist in the submission of Drug Master File (DMF) or Validation Activities and are committed to the quality of our separation products and services.